Media stories about Pro-Dex (NASDAQ:PDEX) have been trending somewhat positive recently, according to Accern Sentiment. The research group identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Pro-Dex earned a news impact score of 0.16 on Accern’s scale. Accern also gave press coverage about the medical instruments supplier an impact score of 45.1467413040158 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Shares of Pro-Dex (PDEX) traded up 6.28% during trading on Friday, reaching $6.60. The company’s stock had a trading volume of 52,011 shares. Pro-Dex has a 12 month low of $3.80 and a 12 month high of $6.65. The company’s 50 day moving average price is $6.19 and its 200 day moving average price is $5.40. The firm has a market cap of $26.49 million, a PE ratio of 5.96 and a beta of -0.39.
COPYRIGHT VIOLATION NOTICE: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact Pro-Dex (NASDAQ:PDEX) Share Price” was first reported by BNB Daily and is the sole property of of BNB Daily. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://www.baseball-news-blog.com/2017/08/19/pro-dex-nasdaqpdex-given-coverage-optimism-score-of-0-16-updated.html.
Pro-Dex, Inc (Pro-Dex) designs and produces surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Company operates through four segments: Pro-Dex, OMS, Fineline and Engineering Services Division (ESD). The Pro-Dex segment provides primarily medical and dental instruments using shared production and assembly machines and workforce.
Receive News & Ratings for Pro-Dex Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex Inc. and related companies with MarketBeat.com's FREE daily email newsletter.